Increased Expression of TIGIT/CD57 in Peripheral Blood/Bone Marrow NK Cells in Patients with Chronic Myeloid Leukemia

Table 1

Sample characteristics.

Factor	HIs-PB	De novo CML-PB	MR-PB	HIs-BM	De novo CML-BM
The number of the case	15	13	18	8	7
Age (median; range) (years)	51 (21-82)	45.5 (32-74)	40 (21-79)	33 (17-51)	40 (32-82)
Gender (male/female)	9/6	9/4	8/10	3/5	4/3
BCR/ABL1 (IS) (%)	—	95.6 (13.4-240.0)	2.35 (0.005-9.1)	—	—
TKI duration (median, range) months	—	—	54 (1-108)	—	—

HIs: healthy individuals; CML: chronic myeloid leukemia; MR: molecular response; PB: peripheral blood; BM: bone marrow; IS: international standard; TKI: tyrosine kinase inhibitor.